The purpose of the study is to identify genetic and biologic markers that may predict the loss of lung function due to idiopathic pulmonary fibrosis. The studies will compare genetic and biologic markers of samples to changes in symptoms. The ultimate goal is to predict if or when patients are likely to experience a rapid decline in lung function due to disease progression.
Patients who are 18 or older
Diagnosis of Idiopathic Pulmonary Fibrosis
Treated at the Simmons Center
Other Lung Illness
Patients aged 18 and older who have been diagnosed with IPF and referred by a Simmons Center doctor.
Cohort
Other
Not listed
Click on the lead sponsor to view all of their trials.
